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The generation and maintenance of genome edited zebrafish lines is typically labor
intensive due to the lack of an easy visual read-out for the modification. To facilitate
this process, we have developed a novel method that relies on the inclusion of an
artificial intron with a transgenic marker (InTraM) within the knock-in sequence of
interest, which upon splicing produces a transcript with a precise and seamless modi-
fication. We have demonstrated this technology by replacing the stop codon of the
zebrafish fli1a gene with a transcriptional activator KALTA4, using an InTraM that
enables red fluorescent protein expression in the heart.
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1 | INTRODUCTION
The manipulation of genomes of model organisms has been a main-
stay of biological research for decades, enabling the study of basic
biological processes and advancing our understanding of disease
mechanisms. In recent years, the advent of precise genome editing
tools, such as CRISPR/Cas9 (Adli, 2018) and related systems
(TALENS, ZNFs) (Bedell et al., 2012; Foley et al., 2009), has enabled
researchers to mimic missense mutations associated with human dis-
eases, generate gain- and loss-of-function gene variants, and precisely
alter genomic loci with reporter tags. However, the generation and
the maintenance of transgenic lines with these modifications can be
difficult and time consuming. In zebrafish, for example, the process of
creating a transgenic line through CRISPR/Cas9 mediated DNA cleav-
age and homology directed repair, involves generating mosaic P0 indi-
viduals, of which only a subset will transmit the transgene through the
germ line. This necessitates screening of hundreds of F1 progeny to
identify stable transgenics. The establishment of transgenic lines with
small modifications or single nucleotide changes is particularly chal-
lenging, as it requires performing PCR on the genomic DNA of
individual animals, without sacrificing them. The addition of the cod-
ing sequence of a fluorescent protein to an endogenous gene should,
in principle, be easier to screen because transgenic animals can be
identified visually with a fluorescence microscope. However, in our
experience, the expression levels of the endogenous proteins are
often so low that the fluorescent tag can only be visualized with a
microscope equipped with a high numerical aperture objective and
sensitive detectors, such as laser scanning or spinning disc confocal
microscope. This requires access to expensive equipment and pains-
taking mounting procedures, both of which are impractical when
screening large numbers of embryos.
Transposon-mediated transgenesis often utilizes a linked marker,
such as the mini-white gene used in Drosophila P-elements (Klemenz,
Weber, & Gehring, 1987) or the myl7:EGFP reporter found in many
zebrafish Tol2 constructs. These markers are easily visually identifi-
able, and substantially streamline the process of transgenic line gener-
ation and maintenance. To bring a similar visible reporter system to
CRISPR/Cas9 knock-ins, we devised a novel genetic element con-
sisting of an artificial intron with a transgenic marker (InTraM). When
inserted into the knock-in cassette, the InTraM allows for easy
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identification of the gene edited animals, but it is spliced out from
mRNAs transcribed from the targeted locus, resulting in the expres-
sion of proteins with precise and seamless modifications.
2 | RESULTS
2.1 | Design of the knock-in cassette with InTraM
As proof-of-principle, we replaced the stop codon of the zebrafish
fli1a gene with the ribosome skipping T2A sequence from Thosea
asigna (Liu et al., 2017) and the coding sequence for KALTA4
(a zebrafish optimized GAL4 transcriptional activator) (Distel,
Wullimann, & Koster, 2009). To make the InTraM we adapted the
intron from the Simian virus 40 small T antigen (previously demon-
strated to function in zebrafish embryos [Collins, Linker, &
Lewis, 2010]), by inserting a reporter gene consisting of the myl7 (also
known as cmlc2) promoter, the coding DNA sequence (CDS) for the
mKate2 fluorescent protein and a herpes simplex virus thymidine
kinase polyA signal (Figure 1a, Supplementary Figure 1a). By 24 hr
postfertilization (hpf), the myl7 promoter is strongly and exclusively
active in the myocardium (Burns et al., 2005). The InTraM sequence
was inserted in the antisense orientation to the T2A-KALTA4 CDS to
prevent interference with the transcription from the targeted locus.
We placed the InTraM between the guanines of the sequence AGG at
position 260 of the KalTA4 CDS to generate consensus splice donor
and acceptor sites (Collins et al., 2010; Roca, Krainer, & Eperon, 2013;
Stephens & Schneider, 1992).
2.2 | Functional testing of an InTraM containing
transgene
We injected the fli1a targeting construct, along with Cas9 mRNA and
target-specific single guide RNA (sgRNA), into Tg[5xUAS:EGFP]zf82
embryos. By 24 hpf mKate2 expression in the myocardium was clearly
detectable with a fluorescence stereomicroscope in a subset of the
injected embryos (Figure 1b,b0). The mKate2-positive embryos also
showed EGFP expression in individual endothelial cells (Figure 1c,c0)
consistent with the expected endogenous expression of the targeted
fli1a gene in mosaic P0 embryos. Repeating the injections in wild-type
embryos resulted in 18% (of more than 800) embryos with detectable
mKate2 expression in the myocardium. We extracted genomic DNA
from 12 mKate2 positive embryos and performed PCR over the inser-
tion site using a forward primer up-stream of the 50 homology arm
and a reverse primer in the KALTA4 sequence. Eight of the 12 reac-
tions resulted in a PCR product of the size expected for precise inser-
tion in the fli1a locus, suggesting that approximately two-thirds of the
mKate2 positive embryos had integrations from homologous recombi-
nation. We raised the remaining mKate2-positive P0 embryos and
from the 34 surviving P0 adults we successfully identified a single Tg
[fli1a-T2A-KalTA4_InTraM(myl7:mKate2)]md75 founder fish using only
the mKate2 myocardial expression in F1 embryos as a readout. PCR
and sequencing of the genomic DNA from F1 embryos demonstrated
that T2A-KalTA4 CDS was inserted in frame into the fli1a CDS. When
F1 fish were crossed to homozygous Tg[5xUAS:EGFP]
zf82 fish, all of the
mKate2-positive progeny displayed robust expression of EGFP in
endothelial cells (Figure 1d). This expression pattern was similar to
that of Tg(fli1a: eGFP)y1 (Figure 1e), further supporting that the expres-
sion of the T2A-KaltA4 CDS is consistent with an integration within
the fli1a locus. Reverse transcription PCR on total RNA from
mKate2-positive F2 embryos, using primers upstream and down-
stream of the InTraM element, produced a single PCR product of the
size expected for a spliced transcript (Figure 1f). Sequencing of this
PCR product confirmed that splicing occurred as expected, demon-
strating that InTraM was efficiently and precisely excised from the
modified transcript (Figure 1g). The level of fli1a expression was
assessed by qPCR using cDNA generated from pools of mKate2 posi-
tive and mKate2 negative embryos from out-crossing the Tg[fli1a-
T2A-KalTA4_InTraM(myl7:mKate2)]md75 line to wild-type fish. The level
of fli1a transcripts in mKate2 positive embryos was 1.3- to 1.4-fold
higher than their mKate2 negative siblings (Figure 1h), suggesting that
integration of the transgene into the fli1a locus resulted in a moder-
ately increased expression relative to that of the endogenous
fli1a gene.
3 | DISCUSSION
The generation of transgenic lines with targeted insertions has been,
and continues to be, challenging in large part due to inefficiencies in
the process. In zebrafish, only a limited number of the injected
embryos will contain cells with targeted insertions, of which only a
small fraction will survive to adulthood and transmit the transgene
F IGURE 1 (a) Schematic representation of the InTRaM knock-in strategy targeting the fli1a endogenous locus. (b,b0) Representative image of
Tg[fli1a: KalTA4_INTRAM(myl7:mKate)], Tg[5xUAS:EGFP]zf82 expression in positive P0 embryos at 52 hpf (transmitted light and mKate2 signal). (c,c0)
In the same embryo, positive endothelial cells can be detected in the trunk at 52 hpf (transmitted light and eGFP). eGFP only signal is shown in
panel c0. (d) Representative image of Tg[fli1a: KalTA4_INTRAM(myl7:mKate)], Tg[5xUAS:EGFP]zf82 expression in F1 embryos at 4 days
postfertilization (dpf) (green channel only). (e) Representative image of Tg[fli1a: eGFP]y1 expression in embryos at 4 dpf. (f) Reverse transcription
PCR on total RNA from mKate2-positive F2 embryos produced a single band of the expected size (416 bp) for spliced transcripts, ladder: New
England Biolab 1 kb ladder. (g) Sequencing of this PCR product demonstrated precise excision of the InTraM from the modified transcript.
(h) qPCR quantification of fli1a expression levels in 72 hpf Tg[fli1a: KalTA4_INTRAM(myl7:mKate)], Tg[5xUAS:EGFP]zf82 mKate2-positive embryos,
compared to mKate2-negative embryos, using two different fli1a primer pairs
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through their germline. We have demonstrated that incorporation of
an artificial intron carrying a transgenic marker into CRISPR/Cas9
mediated knock-in cassette is a powerful strategy for mitigating these
inefficiencies by providing a simple tool to screen out many, if not
most, of the embryos that do not contain targeted insertions. We
found that the expression of fli1a from the targeted locus was higher
than from the endogenous fli1a gene. It is not known if the altered
expression is due to the inclusion of the InTraM or the other compo-
nents of the targeting construct. Any modification of an endogenous
locus carries the risk of altering expression from that locus, and any
alterations in expression is likely to be specific to the targeted gene
and the nature of the modification.
In our proof-of-concept, we inserted additional coding sequences
into the target gene, but the same approach can also be used to edit
genes with small or single nucleotide modifications. By including the
desired modification in the homology arms flanking the InTraM, trans-
genic lines with genes coding for dominant-negative or constitutively
active proteins, or genes with disease associated missense mutations,
can be generated efficiently (Supplementary Figure 1b).
One disadvantage of the CRISPR/Cas9 mediated HDR is the
necessity to clone long homology arms. There are other targeting
methods that rely on nonhomologous end joining repair, such as
Homology Independent Targeted Insertion (HITI) (Suzuki et al., 2016).
However, these methods do not permit seamless modification of the
target CDS, and often introduce small insertions and deletions at the
insertion site (Hruscha et al., 2013; Hwang et al., 2013a). To make use
of the quick and easy cloning of HITI targeting constructs while
retaining the ability to generate precise and seamless protein modifi-
cations, we are currently testing a variant of InTraM that is inserted
into an intron, rather than an exon, of the target gene. In this artificial
Exon with Transgenic Marker (ExTraM), the CDS for the desired modi-
fication is flanked by splice acceptor and donor sites. When the
targeted gene is transcribed, the CDS within the ExTraM is spliced in-
frame with the CDS from the endogenous locus, resulting in the
seamless modification of the translated protein (Supplementary
Figure 1c). We expect that together, the InTraM and ExTraM tech-
niques will enable researchers to generate novel transgenic lines with
precise genome and/or protein modifications in a more efficient
manner.
4 | METHODS
4.1 | Construct sequences
SV40 small T antigen intron has the following sequence:
50 GTAAATATAAAATTTTTAAGTGTATAATGTGTT[reporter
gene]AAACTACTGATTCTAATTGTTTGTGTATTTTAGGA 30.
Tg(fli1a: KalTA4_INTRAM[myl7:mKate]) construct for CRISPR/
CAS9-homology independent targeted integration is available upon
request.
In the final T2A-KALTA4 targeting construct the knock-in cassette
was flanked with 958 bp 50 and 1,146 bp 30 homology arms to
facilitate the CRISPR/Cas9 mediated HDR [4]. Target sites of the
sgRNA were included at the ends of homology arms to allow for plas-
mid linearization upon injection as described in Irion, Krauss, and
Nusslein-Volhard (2014). The construct was assembled using NEB
Builder HiFi DNA Assembly kit (New England Biolabs).
sgRNA was designed using ZiFiT (http://zifit.partners.org/ZiFiT/
references.aspx) and the plasmid for production of sgRNA was gener-
ated as previously described (Hwang et al., 2013b). sgRNA was tran-
scribed using the MEGAscript T7 Transcription Kit (Invitrogen) and
purified using the MEGAclear Transcription Clean-Up Kit (Invitrogen)
following the manufacturer's instructions.
Cas9 mRNA was transcribed from the pT7-Cas9 plasmid (Hwang
et al., 2013b) using the mMESSAGE mMACHINE T7 ULTRA Tran-
scription Kit (Invitrogen).
For reverse transcription PCR and qPCR, 30 mKate positive and
30 mKate negative F2 embryos were flash frozen in liquid nitrogen and
homogenized in 300 μl TRI Reagent Solution (Ambion). Total RNA was
purified using the Direct-zol RNA microprep kit (Zymo Research). To
assess splicing of the InTram cassette, PCR was performed using a forward
primer [CCGGGCTGCAGGAATTCGATAGTCAGCTGTCTCTGTCCCT] 50
to the splice donor site, and a reverse primer [ACGGTAT
CGATAAGCTTGATAGGGACAGAGACAGCTGACT] 30 to the splice
acceptor site. For sequencing, the resulting PCR product was cloned into
EcoRV digested pISceI (Thermes et al., 2002) using the NEB Builder HiFi
DNA Assembly kit. qPCR was performed on a QuantStudio 6 Real Time
PCR system (Applied Biosystems) using two sets of primers: fli1a pair
1 [GCAATAAAATGGTGGGCGGG and AGAGACGGGTCTGCGGG] and
fli1a pair 2: TGAGAAATGTGCTCCGCCTC and CAGAGACGGG
TCTGCGGG]. Each reaction was performed in triplicate, each qPCR mix-
ture contained 0.45 μl ROX (EURx), 0.25 μl uracil-N-glycosylase (UNG,
EURx), 10 μl 2X SYBR green qPCR Master Mix (EURx), 2 μl Primers
(0.5uM each mix), 2 μl of 1:10 dilution of cDNA and 5.3 μl of dH2O. The
efficiency of PCR amplification was determined using LinReg PCR (Ruijter
et al., 2009). Gene expression was normalized to that of the housekeeping
genes rpl13 and rps29. Calculations of fold induction changes were per-
formed following published models (Pfaffl, 2001).
4.2 | Injections
For CRISPR/Cas9 mediated homologous recombination one-cell stage
embryos were injected with 2 nl of 20 ng/μl targeting construct plas-
mid, 125 ng/μl Cas9 mRNA and 25 ng/μl of target specific sgRNA.
The sg target sequence for fli1a was GGTTTAGTAGTAACTACCA
(minus strand), PAM sequence: AGG.
4.3 | Zebrafish husbandry
Zebrafish (Danio rerio) were raised and staged as previously described
(Kimmel, Ballard, Kimmel, Ullmann, & Schilling, 1995). Transgenic lines
used were: Tg[fli1a-T2A-KalTA4_InTraM(myl7:mKate2)]md75, Tg[5xUAS:
EGFP]zf82 and Tg(fli1:EGFP)y1. The wild-type fish used were from a
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cross of the AB and TL strains. For growing and breeding of transgenic
lines, we comply with regulations of the ethical commission animal
science of MDC Berlin and with FELASA guidelines (Alestrom
et al., 2019).
4.4 | Imaging
Embryos were anesthetized in 0.014% tricaine (Tricaine-Pharmaq
1,000 mg/g, PHARMAQ Limited), mounted in plastic petri dishes
(94 × 16 mm - Sarstedt Ref#82.1473) containing 0.014% tricaine, and
bathed in E3 media containing 0.007 (0.5×) to 0.014% (1×) tricaine and
0.003% Phenylthiourea (as indicated). Imaging was performed on an
upright 3i spinning-disc confocal microscope using Zeiss Plan-Apochromat
20× or 40× /1.0 NA water-dipping objectives. Screening of embryos was
performed using a Leica M205 FA stereomicroscope with filter sets ET
GFPM205FA/M165FC and ETmCherryM205FA/M165FC.
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